Cardurion Pharmaceuticals

Cardior

This company develops RNA-based therapeutics designed to prevent, repair and reverse heart diseases for patients with cardiac dysfunctions.

Cardior Pharmaceuticals

This biopharmaceutical company develops RNA-based therapeutics to prevent and repair heart disease for patients with conditions such as heart failure and myocardial infarction.

AnaCardio

This biopharmaceutical company develops oral small-molecule drugs to improve cardiac contractility in patients with heart failure.

Corvidia Therapeutics

This clinical-stage biotechnology company develops precision therapies for patients with chronic kidney disease who are at high risk of cardiovascular events.

Brano Therapeutics

This company develops small-molecule inhibitors to treat heart failure and metabolic dysfunction for patients with cardiovascular diseases.

Braveheart Bio

This biopharmaceutical company develops small-molecule therapeutics to treat patients with hypertrophic cardiomyopathy and other serious cardiovascular conditions.

NanoPhoria

This company develops an inhalable nano-drug delivery platform and therapeutics for patients with heart failure and other cardiovascular diseases.

Corteria

This biopharmaceutical company develops therapeutic drugs for patients with obesity and heart failure subpopulations.